WOOJUNG BIO Inc (215380) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.065x

Based on the latest financial reports, WOOJUNG BIO Inc (215380) has a cash flow conversion efficiency ratio of -0.065x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.51 Billion ≈ $-1.03 Million USD) by net assets (₩23.17 Billion ≈ $15.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of WOOJUNG BIO Inc for the company's overall valuation and market capitalisation.

WOOJUNG BIO Inc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how WOOJUNG BIO Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

WOOJUNG BIO Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of WOOJUNG BIO Inc ranked by their cash flow conversion efficiency. Explore how high is WOOJUNG BIO Inc's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Live Ventures Inc NASDAQ:LIVE	0.103x
KB Autosys Co. Ltd KQ:024120	-0.009x
Gillanders Arbuthnot & Company Limited NSE:GILLANDERS	0.008x
IVP Limited NSE:IVP	0.067x
Seach Medical Group Ltd TA:SEMG	-0.028x
Conduril - Engenharia S.A LS:CDU	N/A
Flap Kongre Toplanti Hizmetleri Otomotiv ve Turizm AS IS:FLAP	-0.004x
Eutilex.Co.Ltd KQ:263050	-0.083x

Annual Cash Flow Conversion Efficiency for WOOJUNG BIO Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of WOOJUNG BIO Inc from 2016 to 2025. View WOOJUNG BIO Inc share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩23.38 Billion ≈ $15.84 Million	₩-630.50 Million ≈ $-427.28K	-0.027x	+29.67%
2024-12-31	₩29.37 Billion ≈ $19.91 Million	₩-1.13 Billion ≈ $-763.37K	-0.038x	+73.85%
2023-12-31	₩21.97 Billion ≈ $14.89 Million	₩-3.22 Billion ≈ $-2.18 Million	-0.147x	-274.16%
2022-12-31	₩29.72 Billion ≈ $20.14 Million	₩2.50 Billion ≈ $1.70 Million	0.084x	+53.31%
2021-12-31	₩31.46 Billion ≈ $21.32 Million	₩1.73 Billion ≈ $1.17 Million	0.055x	+117.95%
2020-12-31	₩28.03 Billion ≈ $19.00 Million	₩-8.57 Billion ≈ $-5.81 Million	-0.306x	-4007.26%
2019-12-31	₩26.66 Billion ≈ $18.07 Million	₩208.72 Million ≈ $141.45K	0.008x	+134.30%
2018-12-31	₩21.20 Billion ≈ $14.37 Million	₩-483.80 Million ≈ $-327.87K	-0.023x	+82.39%
2017-12-31	₩18.32 Billion ≈ $12.42 Million	₩-2.38 Billion ≈ $-1.61 Million	-0.130x	+5.85%
2016-12-31	₩10.57 Billion ≈ $7.16 Million	₩-1.46 Billion ≈ $-986.04K	-0.138x	--

About WOOJUNG BIO Inc

KQ:215380 Korea Biotechnology

Market Cap

$23.95 Million

₩35.34 Billion KRW

Market Cap Rank

#24608 Global

#1768 in Korea

Share Price

₩2120.00

Change (1 day)

-2.97%

52-Week Range

₩1629.00 - ₩3605.00

All Time High

₩13450.00